Adriele Prina-Mello

TL;DR: This review provides state of the art of the nanotechnological applications for cancer therapy and advances a novel concept of personalized nanomedical theranostic therapy using iron oxide magnetic nanoparticles in conjunction with MRI imaging.

TL;DR: The data confirm the hypothesis that, although a proportion of all deposited particles passes through the pleura, the pathogenicity of long CNTs and other fibers arises as a result of length-dependent retention at the stomata on the parietal pleura.

TL;DR: Both clinically available anti-cancer nanomedicines and those en route to future clinical application are discussed, with a focus on their increased performance versus conventional molecular anticancer therapies.

TL;DR: The therapeutic effects of breast cancer magneticHyperthermia could be strongly enhanced by the combination of MF66 functionalized with N6L and DOX and magnetic hyperthermia and represents a straightforward strategy for translation into the clinical practice when injecting nanoparticles intratumorally.

TL;DR: A multi‐step approach of incremental complexity to measure particle size distribution and size stability of NEPs, consisting of a quick preliminary step to assess sample integrity and stability by low resolution techniques (pre‐screening), followed by the combination of complementary high resolution sizing measurements performed both in simple buffers and in complex biological media.